Professional Documents
Culture Documents
U SMLE S t e p 1
Pr e p a r a tio n
C o m pile d b y t h e T T U H S C
Sch ool of Me dicin e
O ffice of S t u d e n t Aff airs
D r. JoAn n Larsen
Assista nt D ea n for Stu dent Affairs
USMLE W h ats it for?
I n ord e r t o b eco m e a lice ns e d p h ysicia n in t h e U nit e d S t a t es, in divid u als m ust p a ss a se ries
of e x a m in a tio ns co n d uct e d b y t h e N a tio n al B o a rd of Me dic al E x a m in e rs. T h es e e x a m in a tio ns
a r e t h e U nit e d S t a t es Me dic al Lice nsin g E x a m in a tio ns, or U SMLE . C u rr e n tly t h e r e a r e fo u r
se p a r a t e e x a m s w hich m ust b e p a sse d in ord e r t o eligible for m e dical lic e nsu r e :
Step
Step
Step
Step
Ho w is Step 1 scored?
W h e n y o u t a k e S t e p 1 , t h e co m p u t e r r ecords y o u r r e sp o nses. Aft e r y o u r t e st e n ds, y o u r
r e sp o ns e s a r e tr a ns m it t e d to t h e N BME for scorin g . T h e n u m b e r of t est it e m s y o u a nsw e r
corr ectly is co n v e rt e d to t w o e q uiv ale n t scor e s, o n e o n a t h r e e - digit scor e sc ale a n d o n e o n a
t w o - digit scor e sc ale . B ot h sc ale s a r e us e d for scor e - r e p ortin g p u rp os es.
O n t h e t h r e e - digit sc ale , m ost S t e p 1 scor e s f all b e t w e e n 1 4 0 a n d 2 6 0 . T h e m e a n scor e for
first - ti m e e x a m in e es fro m a ccr e dit e d m e dic al school pro gr a m s in t h e U nit e d S t a t es is in t h e
r a n g e of 2 0 0 t o 2 2 0 , a n d t h e st a n d a rd d e via tio n is a p pro xi m a t ely 2 0 . Yo u r scor e r e p ort will
inclu d e t h e m e a n a n d st a n d a rd d e via tio n for r ece n t a d m inistr a tio ns of t h e e x a m in a tio n . T h e
t w o - digit scor e is d e riv e d fro m t h e t h r e e - digit scor e . I t is use d in scor e r e p ortin g b ec a us e
so m e m e dic al lice nsin g a u t h orities h a v e r e q uir e m e n ts t h a t inclu d e la n g u a g e d escribin g a
" p a ssin g scor e of 7 5 . " T h e t w o - digit scor e is d eriv e d in such a w a y t h a t a scor e of 7 5 alw a y s
corr e sp o n ds to t h e m ini m u m p a ssin g scor e .
NBME also p u blishes a m ore detailed outline of the topics covered on the Step 1
exa m. Use this as an outline to m ake sure you are coverin g all of these topics in
you r stud y plan. Youll fin d the co m plete outline of w hats on the Step 1 exa m at
the end of this book in Appendix A.
STEP 1 REPORT
6
Student Name
PercentCorrect Overall
54
Percent Correct of 2nd Choices
37
Mean Time per Question
62
Category:
% Correct
Mean Time (sec)
Questions Involving Statistics
61
60
Diagnosis Questions
62
53
Questions Involving Judgement
53
51
Process Questions
49
51
Questions Involving Definitions
51
51
Cause Effect Reasoning Questions
51
51
Questions with Graphics
40
61
Questions Requiring Visualization
43
54
Subject:
% Correct
Mean Time (sec)
Anatomy
43
55
Behavioral Sciences
63
54
Biochemistry
37
45
Microbiology
52
45
Pathology
56
48
Pharmacology
45
55
Physiology
65
62
Question Type:
% Correct
Mean Time (sec)
Multiple Choice
49
52
Extended Foils
55
51
Confidence levels:
% Correct
Number
Mean Time (sec)
1 (low)
16
25
62
2
36
22
69
3
33
15
51
4
74
38
52
5 (high)
75
24
26
Cognitive Level:
% Correct
Mean Time (sec)
Recall
52
45
Comprehension
42
59
Application
63
59
3. ALLO W enoug h tim e to prepare, b ut not too m uch. Alt h o u g h y o u will h a v e
a p pro xi m a t ely 1 0 w e e ks fro m t h e ti m e sch ool e n ds t o t h e d e a dlin e for t a kin g S t e p 1 (Ju n e
3 0 ) , fo u r t o six w e e ks sh o uld b e ple n t y of ti m e t o pr e p a r e for S t e p 1 . Ma n y st u d e n ts in t h e
p a st w h o h a v e t a k e n lo n g e r t h a n 6 w e e ks to pr e p a r e la t e r s aid t h e y felt t h e y t oo k t oo m uch
ti m e , a n d act u ally lost gro u n d wit h t h eir st u d yin g . A n aly sis of o u r o w n st u d e n ts o v e r t h e
y e a rs sh o ws t h a t y o u g e t t h e m ost b a n g for y o u r b uck b y st u d yin g for 6 t o 9 h o u rs p e r d a y
for 4 to 6 w e e ks. B elo w y o ull s e e a gr a p h of h o u rs / d a y a n d w e e ks of st u d yin g gr a p h e d
a g ainst a ct u al S t e p 1 scor e s.
30
3-5 hours per day / 2-4 weeks
3-5 hours per day / 4-6 weeks
25
20
15
10
0
<183
183-199
200-215
216-230
>230
OTHER STEP 1 A DV I CE
Ju d y Sch w e n k e r, K a pla ns C u rriculu m D ir ect or, t alk e d a b o u t t h e w a y s in w hich U SMLE e x a m s
a r e si m ila r t o m e dic al p r a ctice :
1 . y o u m ust fin d k e y infor m a tio n
2 . t h e infor m a tio n y o u n e e d m a y b e b u rie d
3 . t h e r e a r e distr a ctio ns
4 . t h e r e is ti m e pr essu r e
5 . y o u m ust us e pro b a bilities to m a k e d ecisio ns
6 . y o ull n e v e r k n o w it all
7 . sit u a tio ns w o nt e x actly fit w h a t y o uv e le a r n e d
S h e also t alk e d a b o u t t h e m ist a k e s m ost co m m o nly m a d e w h e n pr e p a rin g for S t e p 1 :
1 . p a ssiv e st u d yin g
2 . insufficie n t pr a ctice wit h q u e stio ns
3 . m e m orizin g , n o t u n d e rst a n din g t h e m a t e rial
4 . in a p pro pria t e t est d a y str a t e gies
5 . m isr e a din g or m isin t e rp r e tin g q u estio ns
So w here do I start?
8
10
Block
Block
Block
Block
Block
Block
Block
N o br e a k
5 m in u t e br e a k
5 m in u t e br e a k
3 0 m in u t e lu nch br e a k
N o br e a k
1 0 m in u t e br e a k
D o n e!
1
2
3
4
5
6
7
11
3. Start with the beginning of the question block and work your way to the end. The ide a
h ere is to get into a rh yth m th at will h elp cre ate wh at on e psychologist calls a " Flow " e xperience.
The flow e xperience is a state of optim al concentration and m a xim al perfor m ance.
4. D o not skip a n y q uestions. If y o u d o n't k n o w it w h e n y o u co m e to it , y o u a r e n ot lik ely
t o k n o w it la t e r. S kip pin g a ro u n d w a st e s ti m e a n d c a n e n d u p co nfusin g y o u . D e al wit h e a ch
q u e stio n a s y o u co m e to it , a nsw e r it a s b e st y o u c a n , a n d m o v e o n t o t h e n e x t q u e stio n .
5. Limit your use of the marking feature to no more than two or three questions per
block. Of course you should a nsw er e ach question as you co m e to it, but you m a y w ant to
double-check yourself on a fe w questions. Th e m arking fe ature lets you return to re vie w a nd
reconsider qu estions if you h a v e tim e left ov er. Used correctly, m arking will h elp you re visit
questions where you h a v e a high probability of getting the a nsw er correct. Misused, m arking
ca uses you to not giv e a qu estion your full attention th e first tim e around. You sim ply m a y not h a v e
tim e to go back a nd look at qu estions you h a v e m ark ed, especially if you m ark a lot of th e m .
6. Be ca utio us about ch a ngin g a nsw ers. I n g e n e r al, y o u r o d ds of ch a n gin g a corr ect
a nsw e r to a w ro n g o n e a r e so m uch hig h e r t h a n t h e r e v e rs e t h a t it is si m ply n o t w ort h t h e
risk . If y o u ch a n g e a n a nsw e r, y o u a r e m ost lik ely m a kin g it w ro n g! Yo u r first i m p ulse is
usu ally t h e corr ect o n e . S t a y wit h it u nle ss so m e cle a r insig h t occu rs to y o u .
7. If you finish a question block with time left over, go back and "check" only those
answers that you have previously marked. Checking almost always leads to changing and tends
to reduce your score. If you have a spare mo m ent, m ake sure that you have entered an answer for
every question in the block and then, relax. Sit, take a break, and m entally prepare yourself for the
next block of questions. Focus on the questions to com e, not the ones that are past.
8. Monitor your ti m e. K n o w h o w m uch y o u h a v e left , so y o u d o n o t fin d y o u rs elf r ush e d a t
t h e e n d . W or k o n y o u r p a cin g fro m t h e b e gin nin g of t h e q u e stio n block . C h eck y o u r w a tch
e v e r y 1 0 q u estio ns to m a k e su r e y o u a r e o n t h e corr ect p a ce to finish . If y o u p ace y o u rs elf
t h ro u g h o u t t h e block , y o u sh o uld n ot b e sq u e e z e d for ti m e a t t h e e n d .
9. Relax. D u rin g t h e br e a ks b e t w e e n q u e stio n blocks, tr y t o r ela x a n d n o t t hin k b a ck o v e r
t h e e x a m . T h e d esir e to r ec all q u e stio ns is stro n g , b u t n ot h elpful. T h os e q u estio ns a r e in t h e
p a st ; y o u will n e v e r s e e t h e m a g ain . F ocus o n r ela xin g a n d m a kin g t h e m ost of y o u r br e a k .
R e m e m b e r, y o u will alw a y s t e n d to r e m e m b e r t h ose q u estio ns y o u g e t w ro n g .
12
Kapla n
Visit w w w . k a pla n .co m for m or e infor m a tio n .
Liv e Pr e p co u rs e s a r e 6 - 7 w e e ks in le n g t h . Price is $ 3 , 3 9 9 d o es n ot inclu d e foo d or
a cco m m o d a tio ns.
S t e p 1 Liv e R e tr e a t price is $ 5 , 5 9 9 inclu d e s foo d a n d acco m m o d a tio ns.
O t h e r pro gr a m s a r e a v aila ble .
Location
Atla nta Area
Chicago
Chicago Area
D allas Area
D.C.
Housto n
Mia m i
Step 1
Ja n . 8 - F e b . 1 7 , 2 0 0 7 * * *
Ma r. 1 2 - A pr. 2 9 , 2 0 0 7
Ju n . 1 1 - S e p . 3 0 , 2 0 0 7 * *
Ju n . 1 8 - S e p . 2 3 , 2 0 0 7 *
A pr. 3 0 - Ju n . 1 0 , 2 0 0 7 * * *
A u g . 2 7 - O ct . 6 , 2 0 0 7 * * *
Aug. 6 - Sep. 16, 2007***
Ja n . 2 2 - Ma r. 1 1 , 2 0 0 7
Aug. 13 - Sep. 30, 2007
A pr. 2 3 - Ju n . 1 0 , 2 0 0 7
O ct . 1 - N o v . 1 8 , 2 0 0 7
A pr. 1 6 - Ju n . 1 7 , 2 0 0 7
O ct . 1 5 - D ec. 1 6 , 2 0 0 7
13
Ne w ark ( NJM I )
Ne w York
Pasadena
Ja n . 8 - F e b . 2 5 , 2 0 0 7
Ma r. 5 - Jul. 8 , 2 0 0 7 * *
A u g . 2 7 - D ec. 1 6 , 2 0 0 7 * *
S e p . 3 - D ec. 9 , 2 0 0 7 *
O ct . 1 - N o v . 1 8 , 2 0 0 7
F e b . 2 6 - A pr. 1 5 , 2 0 0 7
Ju n . 1 8 - A u g . 5 , 2 0 0 7
S e p . 1 0 - O ct . 2 8 , 2 0 0 7
Ja n . 8 - F e b . 2 5 , 2 0 0 7
Ma y 2 1 - Jul. 1 , 2 0 0 7
Ma y 2 9 - Jul. 9 , 2 0 0 7 * * *
Philadelp hia
Area
* E x t e n d e dPr e p * * KMI * * * S t e p 1 Pr e p R e tr e a t
E v e nin gs a n d W e e k e n ds W e e k e n ds o nly S t e p 2 Pr e p R e tr e a t
N ot e : A n y of t h e a b o v e Liv ePr e p co u rs e s c a n b e p u rch a s e d a s p a rt of a D elu x ePr e p Pa ck a g e .
May 7 to Ju ne 1, 2 0 0 7
First tim e test takers a n d repeaters with scores at 1 6 8 or above. T his pro gr a m is
m ost b e n e ficial for a st u d e n t w a n tin g a focus e d r e vie w of t h e hig h i m p a ct to pics in a
str uct u r e d , q u e stio n b as e d for m a t .
T h e S u m m e r Pro gr a m off e rs a n in t e nsiv e fo u r w e e k r e vie w of t h e G e n e r al Principle s of
Pa t h olo g y , pr e s e n t e d b y a n a tio n ally r e sp ect e d p a t h olo gist ; critic al clinic al corr ela tio ns
e x plain e d in Bioch e m ist r y , Ph a r m acolo g y , a n d Ph ysiolo g y a n d a B e h a vior al Scie nces / E t hics
r e vie w . S t u d e n ts in t e r act wit h o n e a n o t h e r a n d t h e instr uctors a s t h e y sort o u t co nce p ts t h a t
t h e y u n d e rst a n d inco m ple t ely .
Q u e stio n - b as e d t u t orials h elp p a rticip a n ts t o d e v elo p t h e kin d a n d q u alit y of t hin kin g r e q uir e d
14
for success o n S t e p 1 . D aily s m all gro u p lect u r e r e vie w sessio ns will aid in org a niz a tio n a n d
r e t e n tio n . E m p h a sis is pla ce d o n u n d e rst a n din g of t h e co m m o n dis e a s e s a n d r ela t e d
tr e a t m e n t r e gi m e ns. I n a d ditio n , t h e pro gr a m will pro vid e a dia g n ostic, select e d su b j ect
e x a m s, a n d a m ock b o a rd . Tuition is $ 3 0 0 0.
August 28 to October 20, 2006 (dates not yet announced for 2007)
This 8 - w eek, live lectu re progra m is desig ned both for first tim e test takers w ho
desire a revie w of basic science concepts a n d for the stu dent w ho has scored at 1 6 7
or above on Step 1 a n d w ho is pla n nin g on sittin g for the USMLE Step 1 in early
Nove m ber. S t u d e n ts wit h a hist or y of difficult y o n st a n d a rdiz e d e x a m s a r e m or e lik ely t o b e
succe ssful wit h o u r lo n g e r pr e p a r a tio n pro gr a m b e gin nin g in Ja n u a r y .
As wit h all of o u r co u rs es, focus o n u n d e rst a n din g t h e m a t e rial co v e r e d , pr a cticin g
a p pro pria t e t e st t a kin g str a t e gies, a n d a p plyin g all skills a cq uir e d a n d co n t e n t r e vie w e d in a
co m p u t e r b a se d t estin g e n viro n m e n t . T his liv e lect u r e pro gr a m will inclu d e a r e vie w of
B act e riolo g y , Pa t h olo g y , Ph y siolo g y , I m m u n olo g y , Virolo g y , a n d Bioch e m istr y. Tuition is
$ 4,6 0 0. Housing costs are additional.
F ALCO N P HYS I C I AN R EV I E W S
F or m or e co m ple t e infor m a tio n visit h t t p : / / w w w .f alco n r e vie ws.co m / in d e x . h t m .
Co m plete revie w package includes:
B oo ks
Lu x u r y H ot el Acco m m o d a tio ns
D aily C o n tin e n t al Br e a k f a st a n d Lu nch
O v e r 3 2 5 co n t a ct h o u rs ( S t e p 1 )
O v e r 1 5 , 0 0 0 U SMLE T y p e E x a m Q u e stio ns
G ro u n d tr a nsp ort a tio n to a n d fro m t h e airp ort .
S h u ttle S e r vice t o sh o p pin g , m o vies, a n d ot h e r a r e a s of in t e r est
Step 1 Progra ms inclu d e infor m a tio n fro m : A n a t o m y , Histolo g y , Bioch e m istr y , Micro biolo g y ,
E m br y olo g y , Ph y siolo g y , N e u rolo g y , Ph a r m acolo g y , a n d B e h a vior al Scie nce , plus Clinical
Vig n e t t e s, C a s e Historie s, Gloss y Slid e s, a n d S a m ple T e sts.
REV I E W COURSE DATES for 2 0 0 7 :
Ja n u a r y 8 to F e br u a r y 2 3 - Co urse Full
Ma y 7 t o Ju n e 2 2
Ma y 1 4 t o Ju n e 2 9 (Mia m i)
M a y 1 4 t o Ju n e 2 9 (Phila d elp hia , PA a r e a )
July 1 6 t o A u g ust 3 1
A u g ust 2 0 t o O ct o b e r 5
O ct o b e r 1 t o N o v e m b e r 1 6
(fro m t h e w e bsit e ) : N ort h w est e r n Me dical R e vie w off e rs liv e -lect u r e co u rses in pr e p a r a tio n for
t h e U SMLE a n d C O MLE X S t e p / Le v el 1 , 2 a n d 3 e x a m in a tio ns. T h es e co u rs es a r e d esig n e d to
allo w cu rr e n t m e dical st u d e n ts or gr a d u a tin g in t e r n a tio n al p h ysicia ns t o p a ss t h eir
e x a m in a tio ns in t h eir first a t t e m p t or t o r ais e t h eir pr e vio us scor e s t o a s a tisf a ct or y le v el.
R e vie w pla ns r a n gin g fro m a 3 - d a y q uick r e vie w co u rs e t o a 1 5 - d a y co m pr e h e nsiv e
15
DATE
E a st La nsin g , MI
Ja n u a r y 1 2 - 2 1 ,
2007
E a st La nsin g , MI
F e br u a r y 1 3 - 2 2 ,
2007
$1780
NB I 3 0 0 ( 1 5 - day )
$1380
NB I 3 0 0 ( 1 0 - day )
$1080
F e b 2 4 - 2 5 , Ma rch 3
- 4 , Ma rch 1 0 - 1 1 ,
A pril 1 4 - 1 5 , A pril 2 1
- 2 2 , a n d Ma y 5 - 6 ,
2007
S a t u rd a y s a n d
S u n d a y m ornin gs
E a st La nsin g , MI
Ma y 2 1 - 3 0 , 2 0 0 7
E a st La nsin g , MI
Ju n e 2 - 1 1 , 2 0 0 7
OR
ADHD
(fro m t h e w e bsit e ) T h e Ma rsh all U niv e rsit y Me dical H . E .L.P. Pro gr a m b e g a n in 1 9 8 6 wit h a
visio n of h elpin g m e dical st u d e n ts a n d p h y sicia ns wit h le a r nin g dis a bilities a n d / or A D H D
succe e d aca d e m ically . Since t h a t ti m e , Ma rsh all Me dical H . E .L.P. h a s w or k e d wit h
a p pro xi m a t ely 6 0 0 st u d e n ts fro m a cross t h e U nit e d S t a t e s a n d s e v e r al for eig n co u n trie s. A
fiv e w e e k in t e nsiv e co u rse is h eld fo u r ti m e s e a ch y e a r in Ja n u a r y , Ma rch , Ju n e , a n d
S e p t e m b e r, wit h in divid u al o n e o n o n e s essio ns a v aila ble t h e r est of t h e y e a r. T h ro u g h o u t
t h e in t e nsiv e pro gr a m to pics such a s r e a din g a n d co m pr e h e nsio n , r e a din g r a t e , le a r nin g
str a t e gies, m e m oriz a tio n t ech niq u es, t est - t a kin g skills, e rror a n aly sis, a n d self- est e e m a r e
t a rg e t e d for i m pro v e m e n t .
This 5 - w eek course is held fou r ti m es a year : Ja n u ary, March, Ju ne, a n d Septe m ber.
The cost is $ 4,5 0 0 a nd does not inclu de acco m m odations.
16
17
Youll find a sample 28-day study schedule at the back of this book in Appendix B.
18
p o s t - t r a n sl a tio n a l m o dific a t io n s , i n cl u di n g p h os p h o r y l a t io n , a d d it io n of C H O
u n it s
o prot ein d e gr a d a tio n
str uct u r e a n d fu nctio n of pro t eins
o principle s of prot ein struct u r e a n d foldin g
o e n z y m e s : kin e tics, r e a ctio n m ech a nis m s
o str uct u r al a n d r e g ula tor y prot eins : lig a n d bin din g , self- a sse m bly
o r e g ula tor y pro p e rtie s
e n e rg y m e t a b olis m , inclu din g m e t a b olic s e q u e nce s a n d r e g ula tio n
o g e n e r a tio n of e n e rg y fro m ca rb o h y dr a t es, f a t t y acids, a n d esse n tial a m in o
a cids ; glycoly sis, p e n tos e p h osp h a t e p a t h w a y , trica rb o x ylic acid cy cle ,
k e t o g e n e sis, electro n tr a nsp ort a n d o xid a tiv e p h osp h or yla tio n , glyco g e n oly sis
o stora g e of e n erg y : glucon eog e n esis, glycog e n esis, fatt y acid a n d triglycerid e
sy nth esis
o t h e r m o d y n a m ics : fr e e e n e rg y , ch e m ic al e q uilibria a n d gro u p tr a nsf e r p o t e n tial,
e n e rg e tics of A TP a n d ot h e r hig h - e n e rg y co m po u n ds
m e t a b olic p a t h w a y s of s m all m olecules a n d a ssocia t e d dis e a s es
o bios y n t h e sis a n d d e gr a d a tio n of a m in o a cids ( e g , h o m ocy stin u ria , m a ple s y r u p
u rin e dis e a s e )
o bios y n t h e sis a n d d e gr a d a tio n of p urin e a n d p y ri m idin e n ucle o tid e s
o biosy n t h esis a n d d e gr a d a tio n of lipids ( e g , d y slipid e m ia s, ca r nitin e d eficie ncy ,
a dr e n o g e nit al s y n dro m e s)
o bios y n t h e sis a n d d e gr a d a tio n of p orp h y rins
o g ala ctos e m ia a n d ot h e r s m all su g a r disord e rs
bios y n t h e sis a n d d e gr a d a tio n of ot h e r m a cro m olecule s a n d a ssocia t e d a b n or m alitie s,
co m ple x c a rb o h y dr a t e s ( e g , ly soso m al st or a g e dis e a s e ) , glyco pro t eins, a n d
prot e o glyc a ns ( e g , t y p e I I glyco g e n stor a g e dis e a s e )
o
Biolog y of cells
str uct u r e a n d fu nctio n of cell co m p o n e n ts ( e g , n ucle us, cy tos k ele to n , e n d o pla s m ic
r e ticulu m , pla s m a m e m br a n e )
sig n al tr a nsd uctio n (inclu din g b a sic principle s, r ece p tors a n d ch a n n els, s eco n d
m e ss e n g e rs, sig n al tr a nsd uctio n p a t h w a y s)
cell-cell a n d cell- m a trix a d h esio n
cell m otilit y
in tr acellula r sortin g ( e g , tr a ffickin g , e n d ocy tosis)
cellular ho m eost asis ( e g, turnov er, pH m aint e n a nce, prot e aso m e , ions, solu ble prot eins)
cell cycle ( e g , m itosis, m eiosis, str uct u r e of spin dle a p p a r a t us, cell cycle r e g ula tio n )
str uct u r e a n d fu nctio n of b a sic tissu e co m p o n e n ts (inclu din g e pit h elial cells, co n n ectiv e
tissu e cells, m uscle cells, n e r v e cells, a n d e x tr acellula r m a trix )
a d a p tiv e cell r e sp o ns e to in j u r y
in tr a cellula r a ccu m ula tio ns ( e g , pig m e n ts, f a ts, pro t eins, ca rb o h y dr a t es, m in e r als,
inclusio ns, v a cu ole s)
m ech a nis m s of in j u r y a n d n ecrosis
a p o p tosis
H u m a n develop m ent a n d genetics
e m br y o g e n e sis : pro gr a m m e d g e n e e x pressio n , tissu e diff e r e n tia tio n a n d
m orp h o g e n esis, h o m e otic g e n es, a n d d e v elop m e n t al r e g ula tio n of g e n e e x pr e ssio n
co n g e nit al a b n or m alitie s : principles, p a t t e r ns of a n o m alies, d y s m orp h o g e n esis
principle s of p e digr e e a n aly sis, inclu din g in h e rit a nce p a t t e r ns, occu rr e nce a n d
r ecu rr e nce risk d e t e r m in a tio n
popula tion g e n etics : H ard y - W ein b erg la w, found er effects, m ut a tion-selection e quilibriu m
19
20
o
o
o
o
o
o
o
o
o
co nse n t a n d infor m e d co ns e n t t o tr e a t m e n t
p h y sicia n - p a tie n t r ela tio nships ( e g , e t hical co n d uct , co nfid e n tialit y )
d e a t h a n d d yin g
birt h - r ela t e d issu e s
issu es r ela t e d t o p a tie n t p a rticip a tio n in r ese a rch
in t e r a ctio ns wit h o t h e r h e alt h prof essio n als ( e g , r e f e rr al)
s e x u alit y a n d t h e prof e ssio n ; ot h e r b o u n d a r y issu e s
e t hics of m a n a g e d c a r e
org a niz a tio n a n d cost of h e alt h c a r e d eliv e r y
Multisyste m processes
n u tritio n
o g e n e r a tio n , e x p e n dit u r e , a n d stor a g e of e n e rg y a t t h e w h ole - b o d y le v el
o a ss ess m e n t of n u tritio n al st a t us across t h e lif e sp a n , inclu din g c alorie s, prot ein ,
e ss e n tial n u trie n ts, h y po ali m e n t a tio n
o fu nctio ns of n u trie n ts, inclu din g esse n tial, tr a ns-f a t t y acids, ch olest e rol
o pro t ein -c alorie m aln u tritio n
o vit a m in d e ficie ncie s a n d / or to xicitie s
o m in e r al d eficie ncies a n d t o xicitie s
o e a tin g disord e rs ( e g , o b esit y , a n or e xia , b uli m ia )
t e m p e r a t u r e r e g ula tio n
a d a p t a tio n to e n viro n m e n t al e x tr e m es, inclu din g occu p a tio n al e x p osu r e s
o physical a nd associated disorders (eg, te m perature, radiation, burns, decre ased
at m ospheric pressure, high- altitude sickness, incre ased w ater pressure)
o ch e m ical ( e g , g a ses, v a p ors, s m o k e in h ala tio n , a gricult u r al h a z a rds, v ola tile
org a nic solv e n ts, h e a v y m e t als, principles of p oiso nin g a n d t h e r a p y )
fluid, electrolyte, a nd acid-base bala nce a nd disorders (eg, dehydration, acidosis, alk alosis)
Ph ar m acod y na m ic an d p h ar m acokinetic processes
g e n e r al prin ciples
o ph ar m acokinetics : absorption, distribution, m etabolism , e xcretion, dosage interv als
o m ech a nis m s of dr u g a ctio n , str uct u r e - a ctivit y r ela tio nships
o co nce n tr a tio n - a n d d ose - e ff ect r ela tio nships ( e g , e ffic a cy , p o t e ncy ) , t y p e s of
a g o nists a n d a n t a g o nists a n d t h eir a ctio ns
o in divid u al f a ctors alt e rin g p h a r m a co kin e tics a n d p h a r m a co d y n a m ics ( e g , a g e ,
g e n d e r, dise a se , t ole r a nce , co m plia nce , b o d y w eig h t , m e t a b olic proficie ncy ,
p h a r m a co g e n e tics)
o dr u g sid e e ff ects, o v e rdos a g e , to xicolo g y
o dr u g in t e r actio ns
o r e g ula tor y issu e s ( e g , dr u g d e v elo p m e n t , a p pro v al, sch e d ulin g )
g e n e r al pro p e rties of a u t acoids, inclu din g p e p tid e s a n d a n alo gs, bio g e nic a m in e s,
prost a n oids a n d t h eir in hibitors, a n d s m oot h m uscle / e n d ot h elial a u t a coids
g e n e r al principles of a u to n o m ic p h a r m a colo g y
g e n e r al pro p e rties of a n ti m icro bials, inclu din g m ech a nis m s of actio n a n d r e sist a nce
g e n e r al pro p e rties of a n tin e o pla stic a g e n ts a n d i m m u n osu p pr e ss a n ts, inclu din g dr u g
e ff ects o n r a pidly dividin g m a m m alia n cells
Microbial biolog y a nd infection
m icro bial cla ssific a tio n a n d its b a sis
b a ct e ria a n d b a ct e rial dis e a s es
o str uct u r e a n d co m p ositio n
21
22
fu n d a m e n t al co nce p ts of m e a su r e m e n t
o sc ale s of m e a su r e m e n t
o distrib u tio n , ce n tr al t e n d e ncy , v a ria bilit y , pro b a bilit y
o dis e a s e pr e v ale nce a n d incid e nce
o dis e a s e o u tco m e s ( e g , f a t alit y r a t e s)
o a ssocia tio ns ( e g , corr ela tio n a n d co v a ria nce )
o h e alt h i m p a ct ( e g , risk diff e r e nce s a n d r a tios)
o se nsitivit y , sp ecificit y , pr e dictiv e v alu es
fu n d a m e n t al co nce p ts of st u d y d e sig n
o t y p es of e x p e ri m e n t al st u dies ( e g , clinical trials, co m m u nit y in t e r v e n tio n trials)
o t y p e s of o bse r v a tio n al st u die s ( e g , co h ort , c a se -co n trol, cross-s ectio n al, c a s e
s e rie s, co m m u nit y su r v e y s)
o s a m plin g a n d s a m ple siz e
o su b j ect s electio n a n d e x p osu r e alloc a tio n ( e g , r a n d o m iz a tio n , str a tific a tio n ,
s elf-s electio n , sy st e m a tic a ssig n m e n t )
o o u tco m e a ss e ss m e n t
o in t e r n al a n d e x t e r n al v alidit y
fu n d a m e n t al co nce p ts of h y p ot h esis t estin g a n d st a tistical inf e r e nce
o co nfid e nce in t e r v als
o st a tistic al sig nific a nce a n d T y p e I e rror
o st a tistic al p o w e r a n d T y p e I I e rror
__________________________________________________________
H EMATOPO I ET I C
AN D
Nor m al processes
e m br y o nic d e v elo p m e n t , f e t al m a t u r a tio n , a n d p e rin a t al ch a n g e s
org a n struct u r e a n d fu nctio n
cell / tissu e str uct u r e a n d fu nctio n
o pro d uctio n a n d fu nctio n of e r y t h rocy t e s, h e m o glo bin , O 2 a n d C O 2 tr a nsp ort ,
tr a nsp ort pro t eins
o pro d uctio n a n d fu nctio n of le u k ocy t es a n d t h e ly m p h or e ticula r syst e m
o pro d uctio n a n d fu nctio n of pla t ele ts
o pro d uctio n a n d fu nctio n of co a g ula tio n a n d fibrin oly tic f a ct ors
r e p air, r e g e n e r a tio n , a n d ch a n g e s a ssocia t e d wit h st a g e of lif e
Ab nor m al processes
inf ectio us, infla m m a t or y , a n d i m m u n olo gic disord e rs
o inf ectio ns of t h e bloo d , r e ticulo e n d ot h elial sy st e m , a n d ly m p h a tics
o alle rgic a n d a n a p h yla ctic r e a ctio ns a n d o t h e r i m m u n op a t h olo gic m ech a nis m s
o a cq uir e d disord e rs of i m m u n e d e ficie ncy
o a u t oi m m u nit y a n d a u t oi m m u n e dise a s e s ( e g , C oo m bs p ositiv e h e m oly tic
a n e m ia , cr y o glo b ulin e m ia s, I TP)
o a n e m ia of ch ro nic dis e a s e
o tr a nsfusio n co m plic a tio ns, tr a nspla n t r e j ectio n
tra u m atic a nd m ech a nical injury (eg, m ech a nical injury to erythrocytes, splenic rupture)
n e o pla stic disord e rs ( e g , ly m p h o m a , le u k e m ia , m ultiple m y elo m a )
m e t a b olic a n d r e g ula tor y disord e rs, inclu din g acq uir e d a n d co n g e nit al
o a n e m ia s a n d cy to p e nia s ( e g , iro n d eficie ncy a n e m ia , h e m o glo bin o p a t hies,
h e r e dit a r y sp h e rocy tosis)
o cy t h e m ia
o h e m orr h a gic a n d h e m ost a tic disord e rs ( e g , co a g ulo p a t hie s, D I C )
23
Principles of therapeutics
m ech a nis m s of a ctio n , us e , a n d a d v e rs e e ff ects of dru gs for tr e a t m e n t of disord e rs of
t h e h e m a to p oie tic s y st e m
o bloo d a n d bloo d pro d ucts
o tre at m ent of a ne mia, drugs stim ulating erythrocyte production (eg, erythropoietin)
o dr u gs sti m ula tin g le u k ocy t e pro d uctio n ( e g , G - C S F , G M- C S F )
o a n tico a g ula n ts, t h ro m b oly tic dr u gs
o a n tipla t ele t dr u gs
o a n ti m icro bials ( e g , a n ti m ala rials, a n ti- H I V )
o a n tin e o pla stic a n d i m m u n osu p pr e ssiv e dr u gs
o dr u gs us e d t o tr e a t a cq uir e d disord e rs of i m m u n e r e sp o nsiv e n e ss
ot h e r t h e r a p e u tic m o d alities ( e g , sple n ecto m y , ch ela tin g a g e n ts, r a dia tio n t h e r a p y for
ly m p h o m a s, pla s m a p h e r esis)
Gen der, eth nic, a nd beha vioral considerations affectin g disease treat m ent a nd
prevention, inclu ding psychosocial, cultu ral, occu pational, a nd en viro n m ental
e m otio n al a n d b e h a vior al f a ctors ( e g , die t , d e pr e ssio n a n d i m m u n e r e sp o ns e s, bloo d
d o pin g a m o n g a t hle t e s)
influ e nce o n p e rso n , f a m ily , a n d socie t y ( e g , child h oo d le u k e m ia )
occupation al a nd other en viron m ental risk factors (eg, he a v y m etals, hydrocarbons, le ad)
g e n d e r a n d e t h nic f a ct ors ( e g , h e rb al tre a t m e n ts wit h b o n e m a rro w d e pr e ssio n )
C ENTRAL
AN D
Nor m al processes
e m br y o nic d e v elo p m e n t , f e t al m a t u r a tio n , a n d p e rin a t al ch a n g e s, inclu din g n e u r al
t u b e d e riv a tiv e s, ce r e br al v e n tricle s, n e u r al cr e st d e riv a tiv e s
org a n struct u r e a n d fu nctio n
o spin al cord , inclu din g gross a n a to m y , bloo d su p ply , a n d spin al r e fle x e s
o br ain st e m , inclu din g cr a nial n e r v es a n d n uclei, r e ticula r for m a tio n , gross
a n a to m y , a n d bloo d su p ply
o br ain , inclu din g gross a n a to m y a n d bloo d su p ply ; co g nitio n , la n g u a g e ,
m e m or y ; h y p ot h ala m ic fu nctio n ; li m bic sy st e m a n d e m otio n al b e h a vior ;
circ a dia n r h y t h m s a n d sle e p ; co n trol of e y e m o v e m e n t
o s e nsor y sy st e m s, inclu din g pro prioce p tio n , p ain , visio n , h e a rin g , b ala nce , t a st e ,
a n d olf a ctio n
o m otor s y st e m s, inclu din g br ain a n d spin al cord , b a s al g a n glia a n d ce r e b ellu m
o a u to n o m ic n e r v o us s y st e m
o p e rip h e r al n e r v e
cell / tissu e str uct u r e a n d fu nctio n
24
a x o n al tr a nsp ort
e xcit a ble pro p e rties of n e u ro ns, a x o ns a n d d e n drit e s, inclu din g ch a n n els
s y n t h e sis, st or a g e , r ele a s e , r e u p t a k e , a n d d e gr a d a tio n of n e u ro tr a ns m it t e rs
a n d n e u ro m o d ula t ors
o pr e - a n d p osts y n a p tic r ece p tor in t e r actio ns, trop hic a n d gro w t h f a ct ors
o br ain m e t a b olis m
o glia , m y elin
o br ain h o m e ost a sis : bloo d - br ain b a rrie r ; ce r e b rospin al fluid for m a tio n a n d flo w ;
ch oroid ple x us
r e p air, r e g e n e r a tio n , a n d ch a n g e s a ssocia t e d wit h st a g e of lif e
o
o
o
Ab nor m al processes
inf ectio us, infla m m a t or y , a n d i m m u n olo gic disord e rs ( e g , m e nin gitis, m ultiple
scle rosis, m y a st h e nia gr a vis)
tr a u m a tic a n d m ech a nic al disord e rs ( e g , su b d u r al a n d e pid u r al h e m a to m a s, cord
co m pr essio n , p e rip h e r al n e r v e in j u r y )
n e o pla stic disord e rs, inclu din g pri m a r y a n d m e t a st a tic
a cq uir e d m e t a b olic a n d r e g ula tor y disord e rs ( e g , d eliriu m , R e y e s y n dro m e )
v a scula r disord e rs ( e g , ce r e bro v a scula r occlusio n , v e n o us sin us t h ro m b osis, a rt e rial
a n e u r y s m s, h e m orr h a g e )
s y st e m ic disord e rs a ff ectin g t h e n e r v o us syst e m ( e g , lu p us, dia b e tic n e u ro p a t h y )
idio p a t hic disord e rs a ff ectin g t h e n e r v o us sy st e m
co n g e nit al disord e rs, inclu din g m e t a b olic ( e g , n e u r al t u b e d ef ects, ce r e br al p als y ,
m e n t al r e t a rd a tio n , D o w n s y n dro m e )
d e g e n e r a tiv e disord e rs ( e g , p e rip h e r al n e u ro p a t h y , Alz h ei m e r d e m e n tia , Pa r kinso n
dise a se , H u n tin g t o n dise a se , a m y otro p hic la t e r al scle rosis)
p a ro x y s m al disord e rs ( e g , e pile ps y , h e a d a ch e , p ain s y n dro m e s, a n d sle e p disord e rs
inclu din g n a rcole ps y , r e stle ss le gs s y n dro m e / p e rio dic li m b m o v e m e n t , circ a dia n
r h y t h m disord e rs, p a r a so m nia s)
disord e rs of sp ecial s e ns es ( e g , blin d n e ss, d e afn e ss)
ps ych o p a t h olo gic disord e rs, process es a n d t h eir e v alu a tio n
o e a rly - o ns e t disord e rs ( e g , le a r nin g disord e rs)
o disord e rs r ela t e d to su bst a nce us e
o schiz o p h r e nia a n d ot h e r ps ych otic disord e rs
o m oo d disord e rs
o a n xie t y disord e rs
o so m a tofor m disord e rs
o p e rso n alit y disord e rs
o p h y sic al a n d s e x u al a b us e of childr e n , a d ults, a n d eld e rs
o other disorders (eg, dissociativ e, im pulse control, post-tra u m atic stress disorder)
Principles of therapeutics
m ech a nis m s of a ctio n , us e , a n d a d v e rs e e ff ects of dru gs for tr e a t m e n t of disord e rs of
t h e n e r v o us s y st e m
o a n e st h e tics
o h y p n o tics
o ps ych o p h a r m a colo gic a g e n ts ( e g , a n xioly tics, a n tid e pr e ss a n ts, a n tips ych o tic
a g e n ts, m oo d -st a bilizin g a g e n ts)
o a n tico n v ulsa n ts
o a n alg esics
o sti m ula n ts, a m p h e t a m in e s
o a n tip a r kinso nia n dr u gs
o sk ele t al m uscle r ela x a n ts, b ot ulin u m t o xin
25
Gen der, eth nic, a nd beha vioral considerations affectin g disease treat m ent a nd
prevention, inclu ding psychosocial, cultu ral, occu pational, a nd en viro n m ental
e m otio n al a n d b e h a vior al f a ctors ( e g , dru g a b us e , d e m e n tia , sle e p d e priv a tio n ,
a ccid e n t pr e v e n tio n , p e ts)
influ e nce o n p e rso n , f a m ily , a n d socie t y ( e g , d e v elo p m e n t al dis a bilities, d e m e n tia ,
g e n e r a tio n r e v e rs al, n u tritio n , s eiz u r e s, sle e p disord e rs)
occu p a tio n al a n d ot h e r e n viro n m e n t al risk f a ctors ( e g , b o xin g , c a rb o n m o n o xid e
e x p osu r e )
g e n d e r a n d e t h nic f a ct ors
___________________________________________________
SK I N
AN D
Nor m al processes
e m br y o nic d e v elo p m e n t , f e t al m a t u r a tio n , a n d p e rin a t al ch a n g e s
org a n struct u r e a n d fu nctio n
cell / tissu e str uct u r e a n d fu nctio n , inclu din g b a rrie r fu nctio ns, t h e r m al r e g ula tio n ,
eccrin e fu nctio n
r e p air, r e g e n e r a tio n , a n d ch a n g es associa t e d wit h st a g e of life or e t h nicit y ( e g , s e nile
p u rp u r a , m ale p a t t e r n b ald n e ss, post m e n o p a us al h air ch a n g e s)
skin d e f e nse m ech a nis m s a n d n or m al flor a
Ab nor m al processes
inf ectio us, infla m m a t or y , a n d i m m u n olo gic disord e rs
o bacterial infections (eg, acn e, cellulitis, carbuncle, abscess, n ecrotizing fasciitis,
ga ngrene)
o vir al inf ectio ns ( e g , h e rp es inf ectio ns, chick e n p o x , r u b ella , m e a sles, rose ola ,
v e rr uc a e )
o fu n g al inf ectio ns, inclu din g m y coses, d e r m a to p h y tosis ( e g , tin e a )
o p a r a sitic inf ectio ns ( e g , sc a bies, lic e )
o im m une a nd a utoim m une disorders (eg, discoid lupus erythe m atosus, scleroder m a,
der m ato m yositis, alopecia, psoriasis, urticaria, allergic der m atosis)
tr a u m a tic a n d m ech a nic al disord e rs ( e g , t h e r m al in j u r y , d ecu bit us ulce rs, e ff ects of
ultr a viole t lig h t a n d r a dia tio n )
n e o pla stic disord e rs
o k e r a tin ocy t e s ( e g , s e borr h eic k e r a tosis, a ctinic k e r a tosis, b a s al cell c a rcin o m a ,
sq u a m o us cell c a rcin o m a , a n d ich t h y osis)
o m ela n ocy t e s ( e g , n e vi, m ela n o m a )
o v a scula r n e o pla s m s ( e g , h e m a n gio m a s, K a p osi s a rco m a )
o ot h e r ( e g , T -cell ly m p h o m a , skin a p p e n d a g e t u m ors)
m e t a b olic, r e g ula tor y , a n d str uct u r al disord e rs ( e g , vit a m in d e ficie ncie s,
h y p e r vit a m in osis, h y p e r hidrosis)
v a scula r disord e rs ( e g , v a sculitis, R a y n a u d dis e a s e )
26
________________________________________________
M USCULOSKELETAL S YSTEM
Nor m al processes
e m br y o nic d e v elo p m e n t , f e t al m a t u r a tio n , a n d p e rin a t al ch a n g e s
org a n struct u r e a n d fu nctio n
cell / tissu e str uct u r e a n d fu nctio n
o biolo g y of b o n e s, j oin ts, t e n d o ns, sk ele t al m uscle
o e x e rcis e a n d p h y sic al co n ditio nin g
r e p air, r e g e n e r a tio n , a n d ch a n g e s a ssocia t e d wit h st a g e of lif e
Ab nor m al processes
inf ectio us, infla m m a t or y , a n d i m m u n olo gic disord e rs
o inf ectio us disord e rs ( e g , s e p tic a rt h ritis, Ly m e dis e a s e , ost e o m y elitis)
o infla m m a t or y disord e rs ( e g , fibrositis, sy n o vitis, t e n os y n o vitis)
o im m u nologic disord ers ( e g, rh e u m atoid arthritis, a n k ylosin g spond ylitis,
poly m yositis, syst e mic lupus ery th e m a tosus, d er m a to m yositis, poly m y algia
rh e u m atica )
tr a u m a tic a n d m ech a nic al disord e rs ( e g , fr a ct u r e s, spr ains, str ains, disloc a tio ns,
r e p e titiv e m o tio n in j u rie s)
n e o pla stic disord e rs ( e g , ost e osa rco m a , m e t a st a tic dis e a s e )
m e t a b olic, r e g ula tor y , a n d str uct u r al disord e rs ( e g , d w a rfis m , ost e o g e n e sis
i m p e rf ect a , ost e o m ala cia , ost e o p orosis, ost e o d y stro p h y , go u t , m uscula r d y stro p h y )
v a scula r disord e rs ( e g , p oly a rt e ritis n o d os a , b o n e inf a rcts)
s y st e m ic disord e rs a ff ectin g t h e m usculosk ele t al s y st e m ( e g , dia b e t e s m ellit us)
idio p a t hic disord e rs ( e g , D u p u y tr e n con tr a ct u r e , scoliosis, Pa g e t dis e a s e )
d e g e n e r a tiv e disord e rs ( e g , disc dise a s e , ost e o a rt h ritis)
Principles of therapeutics
m ech a nis m s of a ctio n , us e , a n d a d v e rs e e ff ects of dru gs for tr e a t m e n t of disord e rs of
t h e m usculosk ele t al s y st e m
o n o nst e roid al a n ti-infla m m a tor y dr u gs a n d a n alg e sics
27
m uscle r ela x a n ts
a n tig o u t t h e r a p y ( e g , allo p u rin ol, colchicin e , u ricosu ric dr u gs)
i m m u n osu p pr e ssiv e dr u gs ( e g , glucocorticoids, g old , cy toto xic a g e n ts)
dr u gs aff ectin g b o n e m in e r aliz a tio n ( e g , bisp h osp h o n a t e s, c alcito nin , e stro g e n
a n alo gs)
ot h e r t h e r a p e u tic m o d alities ( e g , r a dia tio n , su rg e r y , ca sts, r e h a bilit a tio n )
o
o
o
o
Gen der, eth nic, a nd beha vioral considerations affectin g disease treat m ent a nd
prevention, inclu ding psychosocial, cultu ral, occu pational, a nd en viro n m ental
e m otio n al a n d b e h a vior al f a ctors ( e g , die t , e x e rcis e , s e a t b elts, bicycle h el m e ts)
influ e nce o n p e rso n , f a m ily , a n d socie t y ( e g , ost e o p orosis, fr a ct u r e s in eld e rly , alco h ol
a b us e , a n d fr a ct u r e s)
occu p a tio n al a n d ot h e r e n viro n m e n t al risk f a ctors ( e g , a t hle t e s, m usicia ns)
g e n d e r a n d e t h nic f a ct ors ( e g , b o n e m a ss)
__________________________________________
R ESP I RATORY S YSTEM
Nor m al processes
e m br y o nic d e v elo p m e n t , f e t al m a t u r a tio n , a n d p e rin a t al ch a n g e s
org a n struct u r e a n d fu nctio n
o air w a y s, inclu din g m ech a nics a n d r e g ula tio n of br e a t hin g
o lu n g p a r e nch y m a , inclu din g v e n tila tio n , p e rfusio n , g a s e xch a n g e
o ple u r a
o n a so p h a r y x a n d sin us es
cell / tissu e str uct u r e a n d fu nctio n , inclu din g su rf a ct a n t for m a tio n , alv e ola r str uct u r e
r e p air, r e g e n e r a tio n , a n d ch a n g e s a ssocia t e d wit h st a g e of lif e
p ul m o n a r y d e f e ns e m ech a nis m s a n d n or m al flor a
Ab nor m al processes
inf ectio us, infla m m a t or y , a n d i m m u n olo gic disord e rs
o inf ectio us dis e a s e s
infectious dise ases of the upper respiratory tract (eg, sinusitis, ph aryngitis)
a cu t e inf ectio us dis e a s e s of t h e lo w e r r espir a tor y tr a ct a n d ple u r a a n d
t h eir co m plic a tio ns ( e g , p n e u m o nia , bro nchiect a sis, a bsce ss, e m p y e m a )
ch ro nic inf ectio us dis e a s e s of t h e lo w e r r espir a t or y tr act ( e g ,
Myco b a ct e riu m , e n d e m ic fu n g al inf ectio ns, N oca rdia / Actin o m y ces)
o i m m u n olo gic disord e rs
alle rgic a n d h y p e rse nsitivit y disord e rs ( e g , a st h m a )
a utoim m une disorders (eg, W egener gra nulo m atosis, Goodpasture
syndro m e)
o infla m m a tor y disord e rs
p n e u m oco nios e s
a cu t e a n d ch ro nic alv e ola r in j u r y ( e g , a cu t e r e spir a tor y distr e ss
s y n dro m e , chlorin e g a s / s m o k e in h ala tio n )
o bstr uctiv e p ul m o n a r y dis e a s e
r estrictiv e p ul m o n a r y dis e a s e ( e g , sa rcoid osis, idio p a t hic fibrosis)
tr a u m a tic a n d m ech a nic al disord e rs ( e g , for eig n b o d y a spir a tio n , p n e u m ot h or a x ,
a t elect a sis, sle e p a p n e a )
n eoplastic disorders (eg, polyps, bronchogenic carcino m a, m esoth elio m a, m etastatic
tu m ors)
28
_________________________________________
C ARD I OVASCULAR S YSTEM
Nor m al processes
e m br y o nic d e v elo p m e n t , f e t al m a t u r a tio n , a n d p e rin a t al ch a n g e s
org a n struct u r e a n d fu nctio n
o ch a m b e rs, v alv e s
o c a rdia c cycle , m ech a nics, h e a rt so u n ds, c a rdia c co n d uctio n
o h e m o d y n a m ics, inclu din g s y st e m ic, p ul m o n a r y , coro n a r y , a n d bloo d v olu m e
o circula tio n in sp ecific v a scula r b e ds
cell / tissu e str uct u r e a n d fu nctio n
o h e a rt m uscle , m e t a b olis m , o x y g e n co nsu m p tio n , bioch e m istr y , a n d s ecr e t or y
fu nctio n ( e g , a trial n a triu r e tic p e p tid e )
o e n d ot h eliu m a n d s ecr e tor y fu nctio n , v a scula r s m oo t h m uscle , m icrocircula tio n ,
a n d ly m p h flo w
o m ech a nis m s of a t h e roscle rosis
o n e u r al a n d h or m o n al r e g ula tio n of t h e h e a rt , bloo d v ess els, a n d bloo d v olu m e ,
inclu din g r e sp o ns e s to ch a n g e in post u r e , e x e rcis e , a n d tissu e m e t a b olis m
r e p air, r e g e n e r a tio n , a n d ch a n g e s a ssocia t e d wit h st a g e of lif e
Ab nor m al processes
inf ectio us, infla m m a t or y , a n d i m m u n olo gic disord e rs
o inf ectio us disord e rs ( e g , e n d oc a rditis, m y oca rditis, p e rica rditis)
o infla m m a tor y a n d i m m u n olo gic disord e rs ( e g , acu t e rh e u m a tic f e v e r, sy st e m ic
lu p us e r y t h e m a tosus, v a sculitis, t e m p or al a rt e ritis)
tr a u m a tic a n d m ech a nic al disord e rs ( e g , t a m po n a d e , v alv ula r dise a se , o bstr uctiv e
ca rdio m y o p a t h y )
n e o pla stic disord e rs
29
Principles of therapeutics
m ech a nis m s of a ctio n , us e , a n d a d v e rs e e ff ects of dru gs for tr e a t m e n t of disord e rs of
t h e c a rdio v a scula r s y st e m
o coro n a r y a n d p e rip h e r al v a so dila tors
o a n tia rr h y t h m ic dr u gs
o a n tih y p e rt e nsiv e dr u gs
o m e a su r es use d t o co m b a t h y p ot e nsio n a n d sh ock
o dr u gs a ff ectin g ch olest e rol a n d lipid m e t a b olis m
o dr u gs aff ectin g bloo d co a g ula tio n , t h ro m b oly tic a g e n ts
o in o tro pic a g e n ts a n d tr e a t m e n t of h e a rt f ailu r e
o i m m u n osu p pr e ssiv e a n d a n ti m icro bial dr u gs
o dr u gs to tr e a t p e rip h e r al a rt e rial dis e a s e
ot h e r t h e r a p e u tic m o d alities ( e g , p a ce m a k e rs, a n gio pla st y , v alv e s, gr a fts, ot h e r
su rgic al proce d u r e s)
Gen der, eth nic, a nd beha vioral considerations affectin g disease treat m ent a nd
prevention, inclu ding psychosocial, cultu ral, occu pational, a nd en viro n m ental
e m otio n al a n d b e h a vior al f a ctors ( e g , s m o kin g , alco h ol, isch e m ic h e a rt dis e a s e ,
o b e sit y , e x e rcis e , die t )
influ e nce o n p e rso n , f a m ily , a n d socie t y ( e g , alt e r e d lif e st yle )
occu p a tio n al a n d ot h e r e n viro n m e n t al risk f a ctors ( e g , str ess)
g e n d e r a n d e t h nic f a ct ors ( e g , h y p e rt e nsio n )
30
inf ectio us disord e rs ( e g , p erit o nitis, h e p a titis, gin giv ost o m a titis, p e p tic ulce r,
g a stritis, e so p h a gitis, tr a v ele rs dia rr h e a , foo d p oiso nin g )
o infla m m a tor y disord e rs ( e g , ch olecy stitis, p a ncr e a titis)
o i m m u n olo gic disord e rs ( e g , C ro h n dis e a s e , ulce r a tiv e colitis)
tr a u m a tic a n d m ech a nic al disord e rs
o m alocclusio n
o hia t us h e r nia
o o bstr uctio n ( e g , v olv ulus, in t ussusce p tio n , e so p h a g e al a tr e sia , a n n ula r
p a ncr e a s, postsu rgic al o bstr uctio n )
o p e rfor a tio n of h ollo w viscus a n d blu n t tr a u m a
o in g uin al, f e m or al, a n d a b d o m in al w all h e r nia s
o eso p h a g e al a n d in t estin al div e rticula ( e g , Meck el div e rticulu m )
n e o pla stic disord e rs, inclu din g b e nig n a n d m alig n a n t
m e t a b olic a n d r e g ula t or y disord e rs ( e g , m otilit y disord e rs, m ala bsorp tio n , h e p a tic
f ailu r e , ch olelit hia sis)
v a scula r disord e rs ( e g , p ort al h y p e rt e nsio n , h e m orr h oids, isch e m ia , a n gio d y spla sia )
s y st e m ic disord e rs a ff ectin g t h e g astroin t e stin al s y st e m
o
Principles of therapeutics
m ech a nis m s of a ctio n , us e , a n d a d v e rs e e ff ects of dru gs for tr e a t m e n t of disord e rs of
t h e g a stroin t e stin al s y st e m
o tre at m ent and prophyla xis of peptic ulcer dise ase a nd gastroesoph age al reflux (eg,
antacids, antisecretory drugs, m otility drugs, m ucosal protectiv e agents, antibiotics)
o dr u gs to alt e r g a stroin t e stin al m o tilit y ( e g , c a t h a rtics, a n tidia rr h e al dr u gs,
a n tie m e tic dr u gs, pro kin e tic dr u gs)
o fluid r e pla c e m e n t ( e g , or al r e h y dr a tio n )
o p a ncr e a tic r e pla ce m e n t t h e r a p y a n d tr e a t m e n t of p a ncr e a titis
o dr u gs for tr e a t m e n t of h e p a tic f ailu r e ( e g , la ct ulos e ) a n d bilia r y dis e a s e ( e g ,
dr u gs to dissolv e g allsto n e s)
o a n ti-infla m m a t or y , i m m u n osu p pr essiv e , a n tin e o pla stic, a n d a n ti m icro bial dr u gs
ot h e r t h e r a p e u tic m o d alities ( e g , su rgical proce d u r e s, st e n ts, f e e din g t u b e s)
Gen der, eth nic, a nd beha vioral considerations affectin g disease treat m ent a nd
prevention, inclu ding psychosocial, cultu ral, occu pational, a nd en viro n m ental
e m otion al a nd beh a vioral factors (eg, peptic ulcer, encopresis, Monda y m orning stom ach)
influ e nce o n p e rso n , f a m ily , a n d socie t y ( e g , infla m m a tor y b o w el dis e a s e , irrit a ble
b o w el dise a s e , p a ncr e a titis a n d alco h ol, ch ro nic la x a tiv e a b us e )
occu p a tio n al a n d o t h e r e n viro n m e n t al risk f a ctors
g e n d e r a n d e t h nic f a ct ors ( e g , die ts)
________________________________________
R ENAL / U R I NARY S YSTEM
Nor m al processes
e m br y o nic d e v elo p m e n t , f e t al m a t u r a tio n , a n d p e rin a t al ch a n g e s
org a n struct u r e a n d fu nctio n
o kid n e y s, u r e t e rs, bla d d e r, u r e t h r a
o glo m e r ula r filtr a tio n a n d h e m o d y n a m ics
o t u b ula r r e a bsorp tio n a n d s ecr e tio n , inclu din g tr a nsp ort proce ss e s a n d prot eins
o u rin a r y co nce n tr a tio n a n d dilu tio n
o r e n al m ech a nis m s in acid - b a se b ala nce
31
____________________________________________
R EPRO DUCT I VE S YSTEM
Nor m al processes
32
33
______________________________________________
E N D OCR I NE S YSTEM
Nor m al processes
e m br y o nic d e v elo p m e n t , f e t al m a t u r a tio n , a n d p e rin a t al ch a n g e s
org a n struct u r e a n d fu nctio n
o h y p ot h ala m us, p ost e rior a n d a n t e rior pit uit a r y gla n d
o t h y roid gla n d
o p a r a t h y roid gla n ds
o a dr e n al cort e x , a dr e n al m e d ulla
o p a ncr e a tic isle ts
o o v a r y a n d t estis
o a dip os e tissu e
cell/ tissue structure and function, including hor m on e synth esis, secretion, action, a nd
m etabolism
o p e p tid e h or m o n e s
o st e roid h or m o n e s, inclu din g vit a m in D
o t h y roid h or m o n e s
o c a t ech ola m in e h or m o n es
o r e nin - a n gio t e nsin sy st e m
r e p air, r e g e n e r a tio n , a n d ch a n g e s a ssocia t e d wit h st a g e of lif e
Ab nor m al processes
inf ectio us, infla m m a t or y , a n d i m m u n olo gic disord e rs ( e g , su b a cu t e t h y roiditis, G r a v es
dis e a s e , s a rcoid osis)
tr a u m a tic a n d m ech a nic al disord e rs
n e o pla stic disord e rs ( e g , pit uit a r y , t h y roid , p a r a t h y roid , a dr e n al cort e x , p a ncr e a tic
isle ts, n e u r al cr e st , p h e och ro m ocy to m a )
m e t a b olic a n d r e g ula tor y proce ss e s ( e g , dia b e t e s m ellit us, pit uit a r y , h y p ot h ala m us,
t h y roid , p a r a t h y roid , p a ncr e a tic isle t disord e rs, a dr e n al disord e rs)
v a scula r disord e rs ( e g , pit uit a r y a po ple x y )
s y st e m ic disord e rs a ff ectin g t h e e n d ocrin e s y st e m
idio p a t hic disord e rs ( e g , hirsu tis m )
Principles of therapeutics
m ech a nis m s of a ctio n , us e , a n d a d v e rs e e ff ects of dru gs for tr e a t m e n t of disord e rs of
t h e e n d ocrin e s y st e m
34
o h or m o n e s a n d h or m o n e a n alo gs
o sti m ula tors of h or m o n e pro d uctio n ( e g , sulfo n ylu r e a s)
o in hibit ors of h or m o n e pro d uctio n ( e g , t hio u r a cils)
o h or m o n e a n t a g o nists
o p ot e n tia t ors of h or m o n e actio n ( e g , t hia z olidin e dio n es)
o a n tio b e sit y a g e n ts
ot h e r t h e r a p e u tic m o d alities ( e g , su rg e r y , r a dia tio n )
Gen der, eth nic, a nd beha vioral considerations affectin g disease treat m ent a nd
prevention, inclu ding psychosocial, cultu ral, occu pational, a nd en viro n m ental
e m otio n al a n d b e h a vior al f a ct ors ( e g , co m plia nce in dia b e t es m ellit us, f a ctitio us use of
insulin , psych o g e nic p oly dipsia )
influ e nce o n p e rso n , f a m ily , a n d socie t y
occupation al a nd other en viron m ental risk factors (eg, radiation e xposure, iodine deficiency)
g e n d e r a n d e t h nic f a ct ors
APPEN D I X B
2 8 - day Step 1 Stu d y Sched ule fro m Georgeto w n School of Medicine
35
36
Day 1
Objective
Self Assessment
Assignments
Complete sample test materials
from NBME
General overview of
material to be covered
Learn about the test, and how to best use First Aid as a
resource.
Basic Metabolism
Lippincott's Biochemistry
2.5 hrs
Day 2
Continue Biochemistry
Objective
Structure & Metabolism
of Carbohydrates
Assignments
Chapters 11, 12, 13 & questions
Source
Lippincott's Biochemistry
Details
Review the digestion of sugars and disorders of fructose,
galactose, and lactose metabolism. Spend more time on
glycogen metabolism, its regulation, and related disorders.
Use Figure 13.7 to memorize the glycogen storage diseases.
Est. Time
3 hrs
Glycolysis
Lippincott's Biochemistry
1.5 hrs
Gluconeogenesis
Lippincott's Biochemistry
1 hr
Lippincott's Biochemistry
1 hr
Lippincott's Biochemistry
1 hr
Source
Details
NBME CD-ROM or download Complete 150 sample questions, and note trouble areas to
from www.nbme.org
focus on.
Est. Time
3 hrs
4 hrs
Day 3
Continue Biochemistry
Objective
Lipid Metabolism
Assignments
Chapter 17 & questions
Source
Lippincott's Biochemistry
Details
Focus on roles of pancreatic lipase and bile salts. Fatty acid
metabolism: know where synthesis occurs, relationship to
glucose metabolism, and role of triacylglycerols for storage of
fatty acids. Review mobilization of and oxidation of fatty acids.
Finally, carefully review eicosanoids, focusing on figure 17.20
Phospholipids &
Glycolipids
Lippincott's Biochemistry
1 hr
Lippincott's Biochemistry
2 hrs
Steroid Hormones
Lippincott's Biochemistry
1 hr
Day 4
Continue Biochemistry
Objective
Protein & Enzymes
Assignments
Chapters 1-4 & questions
Source
Lippincott's Biochemistry
Details
Become familiar with basic properties of amino acids, levels of
protein structure, hemoglobin, and collagen. For enzymes,
focus on appreciating ( not memorizing) the Michaelis-Menten
equation, types of enzyme inhibition, modes of enzyme
regulation, and the use of enzymes in clinical diagnosis.
Est. Time
4 hrs
Digestion of Dietary
Proteins and Nitrogen
Metabolism
Lippincott's Biochemistry
2 hrs
Est. Time
3 hrs
Metabolism of Amino
Acid Carbon Skeletons
Chapter 22
Lippincott's Biochemistry
1 hr
Day 5
Continue Biochemistry
Objective
Assignments
Heme, Porphyrins,
Chapter 23
Serotonin, Histamine and
Catecholamines
Source
Lippincott's Biochemistry
Details
Focus on the porphyrias and bilirubin metabolism. Focus on
figures 23.5 and 23.7.
Est. Time
1 hr
Lippincott's Biochemistry
Know what they are and know the related disorders. Don't get
too bogged down in details - just study figures 14.12 and 15.4,
then move on.
1 hr
Chapters 27, 28
Lippincott's Biochemistry
3 hrs
Nucleotide Metabolism
Chapter 29
Lippincott's Biochemistry
2 hrs
Day 6
Finish Biochemistry
Objective
Integrative Metabolism
Assignments
Chapters 24, 25, 26
Source
Lippincott's Biochemistry
Details
Synthesize the information you've reviewed this week by
studying insulin, glucagon, the fed/starved states, and the
metabolic aspects of diabetes mellitus. Time spent on these
topics will be VERY WORTHWHILE.
Est. Time
5 hrs
Day 7
General Pharmacology
Objective
Pharmacokinetics &
Pharmacodynamics
Assignments
Chapters 1,2
Source
Lippincott's Pharmacology
Details
Study general principles of pharmacology. Specific agents will
be covered with relevant organ systems.
Est. Time
2 hrs
Autonomic Drugs
Chapters 3-7
Lippincott's Pharmacology
5 hrs
Day 8
Begin Microbiology
Objective
Bacteria
Assignments
Chapters 1-15
Source
Clinical Microbiology made
Ridiculously Simple
Details
Rely heavily on charts. Start building buzzword associations
with characterisitics of each organism and how is identified
(with a special stain, culture medium, etc.) Also, time spent
with Qbank questions here will be golden.
Est. Time
10 hrs
Day 9
Continue Microbiology
Objective
Antibiotics
Assignments
Chapters 28-33
Source
Lippincott's Pharmacology
Details
This is high yield material, read, review and continue to do
Qbank questions to keep building buzzword associations.
Est. Time
6 hrs
Fungi
Chapter 20
1.5 hrs
Antifungals
Chapter 34
Lippincott's Pharmacology
1 hr
Day 10
Finish Microbiology
Objective
Viruses
Assignments
Chapters 22-29
Source
Clinical Microbiology made
Ridiculously Simple
Details
This is high yield material, read, review and continue to do
Qbank questions to keep building buzzword associations.
Est. Time
6 hrs
Antivirals
Chapter 37
Lippincott's Pharmacology
1 hr
Parasites
Chapters 30, 31
2 hrs
Antiparasitics
Chapters 35, 36
Lippincott's Pharmacology
1 hr
Underground Clinical
Vignettes - Microbiology
3 hrs
Clinical Vignettes
Day 11
Objective
Review Immunology
Assignments
Part VII
Source
Medical Microbiology &
Immunology: Examination
and Board Review
Details
Excellent, concise summary of immunology.
Cellular Injury
Chapter 1
BRS Pathology
Inflammation
Chapter 2
BRS Pathology
1 hr
Hemostasis
Chapter 3
BRS Pathology
1 hr
Genetic Disorders
Chapter 4
BRS Pathology
Immune Dysfunction
Chapter 5
BRS Pathology
Neoplasia
Chapter 6
BRS Pathology
BRS Pathology
Quickly review
0.5 hr
Nutritional Disorders
BRS Pathology
0.5 hr
Details
Know mechanisms of DNA repair, different types/roles of
RNA, mechanism of translation, and molecular biology
techniques. Focus on figures 30.2, 30.16, 30.19, 30.22,
31.11, 32.9.
Est. Time
3.5 hrs
Chapter 8
Est. Time
4 hrs
0.5 hr
0.5 hr
Day 12
Cellular Biology
Objective
DNA, RNA, Proteins
Assignments
Chapters 30 - 33
Source
Lippincott's Biochemistry
Cell Membranes
Chapter 1
BRS Cell Biology & Histology Know properties of membranes and membrane proteins.
Nucleus
Chapter 2
BRS Cell Biology & Histology Know contents of nuclei, and RNA import/export mechanisms.
0.5 hr
1 hr
1 hr
0.5 hr
Cytoplasm
Chapter 3
Extracellular Matrix
Chapter 4
BRS Cell Biology & Histology Know different types of collagen, basement membrane
composition, and other ECM components.
Chapters 5,6
BRS Cell Biology & Histology Review types of epithelia and locations of each. Review
connective tissue focusing on bone histology.
0.5 hr
1 hr
1.5 hrs
Day 13
Objective
Cell Physiology
Assignments
Chapter 1
Source
BRS Physiology
Details
Know mechanisms of ion transport, action potentials.
Embryology
Chapters 1-4
BRS Embryology
Birth Defects
Chapters 17, 18
BRS Embryology
Exam
Diagnostic Test
Day 14
Thorax
Objective
Embryology of thorax
Assignments
Chapters 5, 11
Source
BRS Embryology
Details
Know the congenital cardiac abnormalities, and fetal
circulation. Also understand the stages of fetal lung
maturation.
Thoracic Anatomy
Chapter 2
(Also use
Netter's Atlas for reference)
3 hrs
Histology of thoracic
viscera
Chapters 11, 15
BRS Cell Biology & Histology Be able to distinguish arteries and veins in cross section.
Understand architecture of the gas diffusion barrier in the
lungs.
1 hr
Est. Time
1 hr
3 hrs
1.5 hrs
2 hrs
Est. Time
3.5 hrs
Day 15
Cardiovascular System
Objective
Cardiovascular
Physiology
Assignments
Chapter 3
Source
BRS Physiology
Details
Review hemodynamics, electrophysiology, cardiac cycle,
blood pressure regulation, responses to exercise, volume loss,
altitude. Understand pre-load, after-load, Frank-Starling curve,
and conduction.
Cardiac Pathology
Chapter 10
BRS Pathology
1.5 hrs
Vascular Pathology
Chapter 9
BRS Pathology
1 hr
Cardiovascular
Pharmacology
Chapters 16-19, 21
Lippincott's Pharmacology
5 hrs
Day 16
Objective
Respiratory Physiology
Assignments
Chapter 4
Source
BRS Physiology
Details
Know the various lung volume measurements, and
understand acid - base disorders.
Respiratory Pathology
Chapter 14
BRS Pathology
Respiratory
Pharmacology
Chapter 22
Lippincott's Pharmacology
Clinical Vignettes
Underground Clinical
Vignettes - Patho-physiology
Histology of Bone
Marrow, Spleen, &
Lymph Nodes
BRS Cell Biology & Histology Familiarize yourself with lymph node architecture, and
understand the spleen. Understand RBC, WBC, platelet
lineages.
Est. Time
1.5 hrs
Est. Time
1.5 hrs
1.5 hrs
0.5 hrs
2 hrs
3 hrs
Day 17
Finish Hematology
Objective
Anemia
Assignments
Chapter 11
Source
BRS Pathology
Details
Know pathophysiology and lab differentiation of various
etiologies of anemias.
Hempatopoietic &
Lymphoreticular
Neoplasia
Chapter 12
BRS Pathology
2 hrs
Hemorrhagic Disorders
Chapter 13
BRS Pathology
1 hr
Est. Time
2 hrs
Drugs affecting
coagulation
Chapter 20
Lippincott's Pharmacology
1.5 hrs
Anticancer Drugs
Chapter 38
Lippincott's Pharmacology
1.5 hrs
Clinical Vignettes
Underground Clinical
Vignettes - Patho-physiology
2 hrs
Day 18
Gastrointestinal System
Objective
Embryology of Gut and
Body Cavities
Assignments
Chapters 10, 16
Source
BRS Embryology
Abdominal Anatomy
Histology of GI Tract
Chapter 6
BRS Cell Biology & Histology Know layers of gut wall. Understand liver structure, portal
blood flow, and bile flow.
GI Physiology
Chapter 6
BRS Physiology
Day 19
Gastrointestinal System
Objective
Gastrointestinal
Pathology
Assignments
Chapter 15
Source
BRS Pathology
Details
Study this chapter thoroughly.
Est. Time
2 hrs
Hepatobiliary and
Exocrine Pancreatic
Pathology
Chapter 16
BRS Pathology
2 hrs
GI Pharmacology
Chapter 24
Lippincott's Pharmacology
2 hrs
Clinical Vignettes
Underground Clinical
Vignettes - Patho-physiology
2 hrs
Source
Details
Day 20
GenitoUrinary System
Objective
Assignments
Details
Understand rotation of gut and related malformations. Know
which structures are derived of foregut, midgut, hindgut, in
addition to vascular supplies.
Est. Time
1.5 hrs
2 hrs
1.5 hrs
1 hr
Est. Time
Embryology of GU
Organs
Chapters 6, 13, 14
BRS Embryology
3 hrs
Chapters 4, 5
3 hrs
Histology of GU Organs
BRS Cell Biology & Histology Know the maturation sequence of spermatocytes and ovarian
follicles. Know the anatomy of the nephron.
3 hrs
Day 21
GenitoUrinary System
Objective
Renal Physiology
Assignments
Chapter 5
Source
BRS Physiology
Diuretics
Chapter 23
Lippincott's Pharmacology
Chapter 17
BRS Pathology
Male Reproductive
Pathology
Chapter 18
BRS Pathology
Female Reproductive
Pathology
Chapter 19
BRS Pathology
Clinical Vignettes
Day 22
Endocrine System
Objective
Histology of Endocrine
System
Assignments
Chapter 13
Source
BRS Embryology
Details
Review structure of endocrine organs, and use an atlas for
additional pictures.
Physiology
Chapter 7
BRS Physiology
2.5 hrs
Chapter 26
Lippincott's Pharmacology
1.5 hrs
Steroid Hormones
Chapter 27
Lippincott's Pharmacology
Details
Est. Time
1.5 hrs
1.5 hrs
1.5 hrs
1 hr
1.5 hrs
2 hrs
Est. Time
1 hr
1 hr
Clinical Vignettes
Underground Clinical
Vignettes - Patho-physiology
EXAM
Day 23
Nervous System
Objective
Assignments
Embryology of Head,
Chapters 7, 8, 9, 10
Neck, & Nervous System
Source
BRS Embryology
Details
Know branchial arches/clefts and their derivatives.
Understand the transition from neural plate to mature CNS.
Know fate of neural crest cells.
2 hrs
Neuroanatomy
Chapters 1-23
6hrs
Test 1
2 hrs
1.5 hrs
Est. Time
3 hrs
Day 24
Nervous System
Objective
Neurophysiology
Assignments
Chapter 2
Source
BRS Physiology
Details
Understand Synaptic transmission and axonal conduction
Neuropathology
Chapter 23
BRS Pathology
2 hrs
Clinical Vignettes
Underground Clinical
Vignettes - Patho-physiology
2 hrs
Neuropharmacology
Lippincott's Pharmacology
Day 25
Musculoskeletal System
Objective
Embryology
Assignments
Chapter 15
Source
BRS Embryology
Details
Histology
Chapters 7, 8, 10
BRS Cell Biology & Histology Review histology of skin, muscle, bone, and cartilage
Est. Time
2 hrs
3.5 hrs
Est. Time
1 hr
3.5 hours
2 hrs
Lippincott's Pharmacology
2 hrs
Day 26
Musculoskeletal System
Objective
Dermatologic Pathology
Assignments
Chapter 21
Source
BRS Pathology
Musculoskeletal
Pathology
Chapter 22
BRS Pathology
Clinical Vignettes
2 hrs
Exam
2 hrs
Day 27
Objective
Clinical Vignettes
Assignments
All cases
Source
Underground Clinical
Vignettes - Behavioral Sci.
Psychotropic Drugs
Chapters 9-12, 13
Lippincott's Pharmacology
Biostatistics
Day 28
Objective
Final Review
Assignments
Exam Logistics
Source
Details
Focus on malignancies (melanoma, SCC, BCC) and refer to a
dermatology atlas so that you can differentiate between them.
Est. Time
1.5 hrs
1.5 hrs
Details
Est. Time
3 hrs
3 hrs
4 hrs
Details
Review Any Remaining Topics and finish practice questions.
Est. Time
4 hrs